Pharmaceuticals giant AbbVie must pay $15 million to the family of a 10-year-old boy who was born with spina bifida after an Illinois jury found the company failed to properly warn doctors about the risk of birth defects associated with Depakote, a prescription drug used to treat bipolar and seizure disorders. [More]
abbvie
Pharmaceutical Companies Accused Of Colluding To Delay Generic Version Of Popular Cholesterol Drug
By 10.10.16
If you’ve got a patent-protected drug that’s bringing in more than $1 billion a year in sales, you stand to lose a significant chunk of that revenue when the patent expires and lower-cost generic versions come on the market. A California prosecutor alleges that a number of drug companies illegally colluded in a nearly decade-long “pay-for-delay” deal intended to prevent the release of a cheaper competitor to a popular cholesterol drug. [More]
